Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review
RSC Medicinal Chemistry · 2024 · 15 (8) · 2585-2600
DOI: 10.1039/d4md00142g ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Mary Sravani Galla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad 500037 India shankar@niperhyd.ac.in …. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
A comprehensive outlook of PROTAC breakthroughs in targeting anti-inflammatory and auto-immune diseases as promising therapeutic approaches for various unresolved disorders.
Autor:innen und Institutionen
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad 500037 India shankar@niperhyd.ac.in shankarnbs@gmail.com.
ORCID-Profile: Nagula Shankaraiah
Zitieren
APA
Galla, M. S., Sharma, N., Mishra, P., & Shankaraiah, N. (2024). Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review. RSC Medicinal Chemistry, 15(8), 2585-2600. https://doi.org/10.1039/d4md00142g
Vancouver
Galla MS, Sharma N, Mishra P, Shankaraiah N. Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review. RSC Medicinal Chemistry. 2024;15(8):2585-2600. doi:10.1039/d4md00142g
BibTeX
@article{Galla2024,
author = {Galla, Mary Sravani and Sharma, Nitika and Mishra, Priyanka and Shankaraiah, Nagula},
title = {Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review},
journal = {RSC Medicinal Chemistry},
year = {2024},
volume = {15},
number = {8},
pages = {2585--2600},
doi = {10.1039/d4md00142g}
}
EUVIMED